WS #4941

The dominant signal in this window is a significant DE-ESCALATION of the Strait of Hormuz crisis, with the S&P 500 erasing its Iran war-driven losses and turning positive for the year (ID 321829048, Bloomberg). This is corroborated by multiple sources: Bloomberg reports the S&P 500 has erased Iran war-driven losses as earnings season begins (ID 321829048), and a separate jetstream post confirms the S&P 500 has officially turned positive for the year (ID 321828129). This suggests risk assets are shrugging off the blockade news, dampening the immediate bearish equity impact previously highlighted. However, a counter-narrative emerges from the oil market: Vitol Group, the world's largest oil trader, has reportedly lost hundreds of millions on wrong-way oil bets due to the war roiling markets and trapping physical supply at the Strait of Hormuz (ID 321829808), indicating ongoing volatility and potential for supply disruptions. Additionally, a high-significance MAG7 development surfaces: Nvidia (NVDA) surges into its ninth straight day of gains (ID 321827728), up 0.29% to $189.17, extending a 14.20% rally over eight sessions and outpacing the S&P 500's 7.46% gain, reinforcing the tech-led bull run narrative. AMD shares also uptick over 20% in a nine-session winning streak (ID 321829221), indicating broad semiconductor strength. Other signals include FedEx (FDX) CFO John Dietrich stepping down effective June 1, with Claude Russ appointed interim finance chief; the company reiterates FY26 guidance and 2029 targets (ID 321826451), which could introduce uncertainty but maintains outlook stability. Allogene Therapeutics (ALLO) launches a $175M public stock offering to fund clinical development and operations (ID 321826139), potentially dilutive but funding growth. Credo Technology Group (CRDO) agrees to acquire DustPhotonics for $750M in cash and ~0.92M common stock (ID 321828069), accelerating expansion into silicon photonics, bullish for CRDO. Sana Biotechnology (SANA) announces a strategic collaboration with Mayo Clinic to improve care in type 1 diabetes and accelerate development of SC451 (ID 321828170), positive for SANA. Navitas Semiconductor (NVTS) appoints Gregory M. Fischer, ex-Broadcom executive, as independent director to its board (ID 321828527), strengthening governance amid strategic transformation. Revolution Medicines (RVMD) announces proposed $750M common stock offering and $250M convertible senior notes offering (ID 321826457), dilutive but funding late-stage oncology pipeline. Geopolitical tensions persist with Hezbollah rejecting Lebanon's direct negotiations with Israel (ID 321828000), potentially escalating regional conflict, but market impact appears muted given equity resilience.